Evidence map›Paper›PMID 41069660›Full record

ArticlePCN reports : psychiatry and clinical neurosciences2025

Factors associated with treatment failure after discharge in inpatients with schizophrenia spectrum disorders: A retrospective observational study.

Yoshitaka Saito, Hiroyuki Muraoka, Takayuki Yokoyama, Katsuichiro Shimizu, Yukihiro Tanno, Nagomi Kida, Taiyo Nishikawa, Shin Miyake, Yukio Kenmotsu, Kosei Kamimura and 11 more

Abstract read
In one paragraph

Article in PCN reports : psychiatry and clinical neurosciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Yoshitaka SaitoDepartment of Psychiatry, Kitasato University School of Medicine Sagamihara Kanagawa Japan.ORCID https://orcid.org/0000-0001-7159-8650
Hiroyuki MuraokaDepartment of Psychiatry, Kitasato University School of Medicine Sagamihara Kanagawa Japan.
Takayuki YokoyamaDepartment of Psychiatry, Kitasato University School of Medicine Sagamihara Kanagawa Japan.
Katsuichiro ShimizuDepartment of Psychiatry, Kitasato University School of Medicine Sagamihara Kanagawa Japan.
Yukihiro TannoDepartment of Psychiatry, Kitasato University School of Medicine Sagamihara Kanagawa Japan.
Nagomi KidaDepartment of Psychiatry, Kitasato University School of Medicine Sagamihara Kanagawa Japan.
Taiyo NishikawaDepartment of Psychiatry, Kitasato University School of Medicine Sagamihara Kanagawa Japan.
Shin MiyakeDepartment of Psychiatry, Kitasato University School of Medicine Sagamihara Kanagawa Japan.
Yukio KenmotsuDepartment of Psychiatry, Kitasato University School of Medicine Sagamihara Kanagawa Japan.
Kosei KamimuraDepartment of Psychiatry, Kitasato University School of Medicine Sagamihara Kanagawa Japan.
Hirohito KatoDepartment of Psychiatry, Kitasato University School of Medicine Sagamihara Kanagawa Japan.
Yuka NoguchiDepartment of Psychiatry, Kitasato University School of Medicine Sagamihara Kanagawa Japan.
Seita TsuchidaDepartment of Psychiatry, Kitasato University School of Medicine Sagamihara Kanagawa Japan.
Ryutaro SuzukiDepartment of Psychiatry, Kitasato University School of Medicine Sagamihara Kanagawa Japan.
Yuki YoshimuraDepartment of Psychiatry, Kitasato University School of Medicine Sagamihara Kanagawa Japan.
Shoko MiuraKitasato University Health Care Center Sagamihara-shi Kanagawa Japan.
Shunsuke KamitaniDepartment of Psychiatry, Kitasato University School of Medicine Sagamihara Kanagawa Japan.
Takaaki HirookaDepartment of Psychiatry, Kitasato University School of Medicine Sagamihara Kanagawa Japan.ORCID https://orcid.org/0009-0008-6051-0148
Enami SawayamaDepartment of Psychiatry, Kitasato University School of Medicine Sagamihara Kanagawa Japan.
Satoru OishiDepartment of Psychiatry, Kitasato University School of Medicine Sagamihara Kanagawa Japan.
Ken InadaDepartment of Psychiatry, Kitasato University School of Medicine Sagamihara Kanagawa Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: Schizophrenia spectrum disorders are among the most serious mental illnesses that cause social dysfunction. Patients with schizophrenia spectrum disorders are prone to recurrence, and those who require hospitalization are at a high risk; hence, preventing treatment failure after discharge is essential. Therefore, we conducted a retrospective study to identify the factors associated with treatment failure after discharge in patients with schizophrenia spectrum disorders who received psychiatric inpatient treatment. Methods: This study included 859 patients diagnosed with schizophrenia spectrum and other psychotic disorders who were hospitalized at the Department of Psychiatry in Kitasato University Hospital and Kitasato University East Hospital from January 1, 2014, to December 31, 2021. Treatment failure was defined as discontinuation of outpatient care, psychiatric hospitalization, or death within 1 year after discharge. Results: Of the 859 patients, 201 (23.4%) experienced treatment failure. Treatment failure rate was 29.0% in patients undergoing antipsychotic polypharmacy, significantly higher than that in patients who were not. Additionally, treatment failure was 20.8% in patients who had a trial overnight stay at home during hospitalization, significantly lower than that in patients who did not. Conclusion: Antipsychotic polypharmacy at discharge was associated with treatment failure in patients with schizophrenia spectrum disorders. Additionally, trial overnight stays at home during hospitalization potentially contributed to preventing treatment failure. Therefore, preventing treatment failure in patients with schizophrenia spectrum disorder requires optimizing pharmacotherapy and implementing social and environmental adjustments, focusing on the post-discharge period.

Indexed as

polypharmacyschizophreniatreatment failure

Identifiers

PMID41069660
PMCPMC12504128

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.